MEGAN CHEATHAM: Open Payments
NPI 1285344739 · BLUE RIDGE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,195 in 31 payments from 11 companies in 2025. Trend: 2023 $371 · 2024 $616 · 2025 $1,195
Food & beverage: $1,130Education: $65
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 9 | $447 |
| Novo Nordisk Inc | 7 | $247 |
| Amgen Inc. | 3 | $153 |
| BeOne Medicines USA, Inc. | 1 | $129 |
| Otsuka America Pharmaceutical, Inc. | 3 | $63 |
| ABBVIE INC. | 3 | $58 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $23 |
| PFIZER INC. | 1 | $20 |
| Exact Sciences Corporation | 1 | $18 |
Products named: Korlym, EVENITY, Ozempic, TEVIMBRA, REXULTI, Quviviq, XIFAXAN, VRAYLAR.
Industry payments across GA — which companies pay providers there.
